X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

    EU Drug Manufacturing Law Changes Disappoint Manufacturers

    AMR Is The Main Focus of New Research Consortium In World

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Gene Silencing Alzheimers Drug, A World First, Shows Promise

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Australia Falling Short In Biotech Research Funding – Study

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Viral Infections Curbed By Gene Scissors In Human Cells

    Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment

    Neurodevelopmental Issue Leads To Testicular Cancer Risk

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Malaria Immunity Boosted By Matrix-M, Saponin Based Adjuvant

    The UK begins the biggest ever immunization program

    New Approach Brought By Singapore For Pneumococcal Vaccines

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

    EU Drug Manufacturing Law Changes Disappoint Manufacturers

    AMR Is The Main Focus of New Research Consortium In World

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Gene Silencing Alzheimers Drug, A World First, Shows Promise

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Australia Falling Short In Biotech Research Funding – Study

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Viral Infections Curbed By Gene Scissors In Human Cells

    Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment

    Neurodevelopmental Issue Leads To Testicular Cancer Risk

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Malaria Immunity Boosted By Matrix-M, Saponin Based Adjuvant

    The UK begins the biggest ever immunization program

    New Approach Brought By Singapore For Pneumococcal Vaccines

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

EU Drug Manufacturing Law Changes Disappoint Manufacturers

Content Team by Content Team
3rd May 2023
in Drug Development, News

The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws. The changes have gone on to cause controversy among the manufacturers, with some even opining that they might as well leave the region if the laws actually take effect. That said, as per the announcement made by Stella Kyriakides, the EU Health Commissioner, the transformation will go on to provide EU citizens with more accessible, affordable, and novel medicines.

It is well to be noted that the reforms will fall within the wider EU health plan from 2021 to 2027, in which one of the objectives is the affordability of medicines for members. The revision aims to address the limitations of the industry and, at the same time, increase the supply chain within Europe so that there is more access to the medicines. The step also looks into addressing environmental challenges and taking tangible action when it comes to antimicrobial resistance.

The anticipation is that these changes might as well benefit not just Europe but also third parties of the EU, for instance, the associated countries, by sharing a more robust global supply chain from Europe across the rest of the world.

The program is going to have changes when it comes to data exclusivity, which means that other companies will be able to make use of the work done by their competition sooner than in the present scenario. Significantly, the public has viewed these changes more positively after many were upset at how the healthcare sector has gone on to struggle right from the time the pandemic began.

That said, the changes have also prompted some pushback from the drug manufacturing sector. Many of the costs are directly passed on to the manufacturer, with some even giving serious thought to moving away from Europe. This attitude is indeed at its peak, as there happen to be more profitable markets in certain other countries, like the largely unregulated ones in the US and China. According to the CEO of a pharmaceutical major, sharing data within such a time frame can have a damaging impact on Europe.

Previous Post

AMR Is The Main Focus of New Research Consortium In World

Next Post

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

Related Posts

Drug Development

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

3rd May 2023
News

AMR Is The Main Focus of New Research Consortium In World

2nd May 2023
Korean Company GenKOre Offering Genetic Base-Editing Tech
Drug Development

Gene Silencing Alzheimers Drug, A World First, Shows Promise

29th April 2023
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Australia Falling Short In Biotech Research Funding – Study

29th April 2023
Catalent acquires cell and gene therapy-focused MaSTherCell for $315m
News

Viral Infections Curbed By Gene Scissors In Human Cells

29th April 2023
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment
News

Neurodevelopmental Issue Leads To Testicular Cancer Risk

27th April 2023
Next Post

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

Latest News

Drug Development

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

3rd May 2023
Drug Development

EU Drug Manufacturing Law Changes Disappoint Manufacturers

3rd May 2023
News

AMR Is The Main Focus of New Research Consortium In World

2nd May 2023
Korean Company GenKOre Offering Genetic Base-Editing Tech
Drug Development

Gene Silencing Alzheimers Drug, A World First, Shows Promise

29th April 2023
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Australia Falling Short In Biotech Research Funding – Study

29th April 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In